Representative genes involved in these pathways include GNB1, JAK1, RPS3, MAPK3, and IL6, suggesting that transcriptional responses in T2DM converge on inflammatory, oncogenic, and neurodegenerative signaling axes. The gene discussed is MAPK3; the disease is type 2 diabetes mellitus.